The Journal of Global Drug Policy and Practice is an international journal with the goal of bridging the information gap on drug policy issues between the medical-scientific community, policymakers, practitioners and the lay public. Our intended readership includes clinicians, clinical researchers, policymakers, prevention specialists and other persons interested in understanding drug policy issues or in providing drug policy recommendations. The Journal of Global Drug Policy and Practice is a joint effort of the Institute on Global Drug Policy and the International Scientific and Medical Forum on Drug Abuse.
The Institiute on Global Drug Policy is an alliance of physicians, scientists, attorneys and drug specialists advocating public policies that curtail the use of illicit and misuse of licit drugs and alcohol.
The International Scientific and Medical Forum on Drug Abuse is a brain trust of the world's leading researchers involved in drug-related research and physicians concerned about the drug abuse problem. This group helps to dispel misinformation related to current drug issues in the media.
Our Editorial Board consists of respected professionals in drug policy, practice and substance abuse prevention.
Andrea G. Barthwell, MD, FASAM
Peter Bensinger, Bensinger, Dupont & Associates, Former Administrator of the United States Drug Enforcement Administration
Robert L. DuPont, MD, President of the Institute for Behavior and Health, Inc.
David G. Evans, Esq., Drug Free Schools Coalition
Calvina Fay, MBA, Executive Director, Drug Free America Foundation
John F. Gilligan, Ph.D., President and CEO, Human Service Center
David A. Gross, MD, DLFAPA Chair, International Scientific and Medical Forum on Drug Abuse
Edward A. Jacobs, MD, Everett Clinic
Ambassador (RET) Melvyn Levitsky, Professor, Geral R. Ford School of Public Policy, University of Michigan
Colin Mangham, Ph.D., Population Health Promotion Associates, Canada
Ian Oliver, Ph.D.
(Albert) Stuart Reece, MBBS(Hons.), FRCS (Ed.), FRCS(Glas.), FRACGP, MD(UNSW)
Kevin A. Sabet, Ph.D., Director, University of Florida, Division of Addiction Medicine, Drug Policy Institute; Former Senior Advisor to the Director of ONDCP
Peter Stoker, C. Eng., MICE (Retd.), Director, National Drug Prevention Alliance
Eric A. Voth, MD, FACP, Chairman of the Institute on Global Drug Policy
to receive email updates on upcoming issues.
We welcome submissions. Information for Authors